All articles tagged with #minoxidil
Medicines often find new uses after their initial purpose; sildenafil, finasteride, and minoxidil were repurposed from heart, prostate, and blood-pressure indications to treat erectile dysfunction and hair loss, illustrating how serendipity and careful observation drive medical progress and highlighting the benefits and caveats of drug repurposing in men's health.
A We Are Austin feature explains how advancements in hair restoration span non-surgical options like finasteride, minoxidil, PRP therapy, and laser treatments to surgical hair transplantation using donor hair. Experts emphasize starting intervention early to slow loss and preserve hair, while discussing patient selection, the importance of follow-up, and the availability of both scalp and body donor hair for density improvements.
Biotin, a popular supplement for hair regrowth, can interfere with lab tests used to monitor cancer treatment, causing falsely high/low results and potentially delaying or altering therapy. Doctors advise stopping biotin at least 72 hours before blood tests; for hair loss management, FDA-approved topical minoxidil is a safer alternative. Many patients take biotin without realizing the risk, and clinicians urge discussing hair-loss strategies with oncologists.
A dermatologist explains that female hair thinning is usually due to androgenetic alopecia or telogen effluvium, with minoxidil being the most studied treatment and requiring ongoing use. The piece also highlights ingredients to look for in leave-in products and lists 13 researched products (serums, oils, and shampoos) that are supported by science or editor testing; the author reports early improvements after six weeks when addressing vitamin deficiencies and using targeted scalp care, though results vary and professional guidance is advised.
A hair-loss guide highlighting minoxidil’s role and five top men’s products: Ulo Minoxidil + Tretinoin Plus (7% minoxidil), Men’s Rogaine 5% Minoxidil Foam, Happy Head Oral Minoxidil, RootStim 5% Minoxidil Spray, and hims Topical Finasteride & Minoxidil Spray. The piece notes 5% minoxidil as the FDA-approved starting dose, with options for higher concentrations; results typically appear after 2–6 months, and potential side effects include scalp irritation, temporary shedding, and, for oral minoxidil, cardiovascular risks. It also covers differences between topical and oral forms and encourages consults with a dermatologist for personalized guidance.
The Healthline piece surveys current and prospective hair‑loss treatments, highlighting established options finasteride and minoxidil as effective, affordable therapies, noting three FDA‑approved JAK inhibitors (Olumiant, Litfulo, Leqselvi) for alopecia areata with safety warnings, and surveying emerging approaches such as clascoterone, PP405, ET-02, stem-cell therapies, and fatty‑acid treatments. While these newer options show promise, many are still in early trials, and long‑term durability and safety remain uncertain. Experts emphasize early intervention and consulting ABHRS‑certified physicians for accurate diagnosis and personalized treatment planning.
UK/Pakistan researchers report that a biodegradable gel made from the DNA sugar deoxyribose, when applied daily to shaved balding mice, triggered robust hair regrowth comparable to minoxidil, with no additional boost when combined with minoxidil; the effect is linked to increased blood supply to hair follicles, suggesting a potential new alopecia treatment, though findings are early and limited to male mice.
A recent study suggests that combining the natural compound stevioside from stevia with microneedling techniques may enhance the effectiveness of minoxidil in promoting hair regrowth, at least in mice. The research indicates stevioside could act as a natural absorption enhancer, allowing more minoxidil to penetrate the skin and stimulate hair growth. However, further studies are needed to confirm safety and efficacy in humans, and DIY application without professional guidance is not recommended.
Scientists have developed a new dissolving microneedle patch using stevioside from Stevia to enhance minoxidil absorption, showing promising hair regrowth results in mice, potentially offering a more effective treatment for baldness in humans.
A study suggests that adding the natural sweetener stevioside to microneedle patches can significantly improve the delivery and effectiveness of minoxidil for treating androgenetic alopecia, showing promising results in mice and potential for future human applications.
Research suggests that stevioside, a compound from Stevia, can enhance the delivery and effectiveness of minoxidil for hair regrowth, potentially leading to more natural and efficient treatments for alopecia, as demonstrated in mouse studies with a dissolving patch. Further research is needed to confirm safety and efficacy in humans.
Researchers have found that stevioside, a natural compound from the Stevia plant, can enhance the absorption of minoxidil, a common hair loss treatment, leading to improved hair growth in a mouse model of alopecia. This discovery could lead to more effective and natural therapies for androgenetic alopecia, benefiting millions worldwide.
Scientists in China and Australia developed a dissolving patch combining stevia and minoxidil that enhances drug absorption and promotes hair regrowth in mice, offering a promising new approach for treating baldness, though human trials are still needed.
A low-dose blood pressure medication, minoxidil, originally used for hypertension, is showing promise in promoting hair regrowth in women, with a systematic review indicating nearly half of users experience improved hair growth and minimal side effects.
A group of international dermatology experts has endorsed the use of low-dose oral minoxidil as an alternative treatment for hair loss, potentially expanding its use beyond the traditional topical form. While oral minoxidil is currently an off-label treatment, it may offer advantages such as avoiding scalp irritation and being more cost-effective. However, it carries potential heart risks, and patients with certain heart conditions should avoid it. The consensus aims to provide guidance for dermatologists to confidently prescribe this emerging treatment.